Abstract
Histone deacetylase (HDAC) overactivity in colorectal cancer (CRC) promotes cancer progression. In the current study, we showed that 4SC-202, a novel class I HDAC inhibitor (HDACi), potently inhibited survival and proliferation of primary human colon cancer cells and established CRC lines (HT-29, HCT-116, HT-15, and DLD-1). Yet, the same 4SC-202 treatment was non-cytotoxic to colon epithelial cells where HDAC-1/-2 expressions were extremely low. 4SC-202 provoked apoptosis activation in CRC cells, while caspase inhibitors (z-VAD-CHO and z-DVED-CHO) significantly alleviated 4SC-202-exerted cytotoxicity in CRC cells. Meanwhile, 4SC-202 induced dramatic G2-M arrest in CRC cells. Further studies showed that AKT activation might be an important resistance factor of 4SC-202. 4SC-202-induced cytotoxicity was dramatically potentiated with serum starvation, AKT inhibition (by perifosine or MK-2206), or AKT1-shRNA knockdown in CRC cells. On the other hand, exogenous expression of constitutively active AKT1 (CA-AKT1) decreased the sensitivity by 4SC-202 in HT-29 cells. Notably, 4SC-202, at a low concentration, enhanced oxaliplatin-induced in vitro anti-CRC activity. In vivo, we showed that oral gavage of 4SC-202 inhibited HT-29 xenograft g...Continue Reading
References
Mar 21, 2002·Nature Reviews. Cancer·P MarksW K Kelly
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Feb 17, 2005·Molecular and Cellular Biology·Hong DuanLinda M Boxer
Mar 23, 2005·Cancer Research·Mohamed RahmaniSteven Grant
Sep 28, 2005·The Journal of Biological Chemistry·Chang-Shi ChenChing-Shih Chen
Oct 13, 2006·British Journal of Cancer·S EggingtonJ Chilcott
Jul 11, 2007·The Cancer Journal·Ki Young Chung, Leonard B Saltz
Mar 11, 2008·Epigenetics : Official Journal of the DNA Methylation Society·John M Mariadason
Oct 1, 2008·Cancer Letters·Olaf WittIna Oehme
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J O'Connell
Jul 23, 2009·The Journal of Pharmacology and Experimental Therapeutics·Esther P JaneIan F Pollack
Jun 24, 2010·Molecular Cancer Therapeutics·Hiroshi HiraiHidehito Kotani
Jan 29, 2011·Cell Cycle·Jennifer JurkinChristian Seiser
Mar 4, 2011·Cell Death & Disease·Q-y ZhuY Yang
Feb 6, 2013·Nature Reviews. Clinical Oncology·Ernst J KuipersMichael Bretthauer
Sep 26, 2013·Molecular Biology Reports·Li-sen QinLin-shan Fu
Nov 16, 2013·Nature Reviews. Drug Discovery·Jonas W HøjfeldtKristian Helin
Nov 20, 2013·Journal of Experimental & Clinical Cancer Research : CR·Giuseppe ToniniDaniele Santini
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 15, 2014·Bioconjugate Chemistry·Marwa M AfifiMostafa A El-Sayed
Jan 22, 2014·Nature Reviews. Clinical Oncology·Hans-Joachim Schmoll, Alexander Stein
Mar 20, 2014·Nature Reviews. Clinical Oncology·Manisha PaltaChristopher G Willett
Aug 19, 2014·Nature Reviews. Drug Discovery·Katrina J Falkenberg, Ricky W Johnstone
Jan 7, 2015·Nature Reviews. Clinical Oncology·Joleen M Hubbard, Axel Grothey
Feb 19, 2015·Cancer Biology & Therapy·Chen LiPei-Hua Lu
May 31, 2015·Journal of Experimental & Clinical Cancer Research : CR·Li-sen QinShi-ming Zhang
Jun 1, 2015·Biochemical and Biophysical Research Communications·Weihong XuJie Shen
Jun 10, 2015·Current Opinion in Pharmacology·Tamara MaesCarlos Buesa
Citations
Oct 27, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·John A Halsall, Bryan M Turner
Feb 22, 2017·Protein Science : a Publication of the Protein Society·Ken InuiMonika M Golas
Oct 18, 2018·Cancer·Toby A EyreMark R Middleton
Apr 27, 2019·Cancer Medicine·Yuan HeJuan Xia
Jan 20, 2017·Oncotarget·Chunxian ZhouDongfeng Xu
Dec 10, 2017·Oncotarget·Cuiping DaiCaiping Xue
Dec 17, 2017·Oncotarget·Mingming ZhangXiaoping Zou
Sep 17, 2016·Oncotarget·Julian C BahrSusan E Bates
Oct 27, 2016·Oncotarget·Jian-Ping LiWei-Hao Sun
Jun 3, 2016·Targeted Oncology·Maria PinkerneilGünter Niegisch
May 26, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Q D MaoX S Liu
Mar 20, 2019·Journal of Hematology & Oncology·Marion WobserRoland Houben
Apr 26, 2019·Journal of Cellular Physiology·Saleheh RezapourAli Hassanzadeh
Nov 4, 2017·Brain Sciences·Shanta M MesserliRatan D Bhardwaj
Mar 15, 2019·Cell Communication and Signaling : CCS·Mingming ZhangXiaoping Zou
Mar 27, 2020·Cancers·Mariah M HoffmanShanta M Messerli
Jun 28, 2019·Frontiers in Pharmacology·Srinivas Patnaik, Anupriya
Nov 6, 2020·OncoTargets and Therapy·Yuan HeJuan Xia
Dec 4, 2020·International Journal of Molecular Sciences·Yuxiang Luo, Huilin Li
Feb 11, 2021·Cancers·Robert JenkeThomas Büch
Mar 15, 2021·European Journal of Medicinal Chemistry·Piyush GediyaManjunath D Ghate
Sep 22, 2020·Biochemical Pharmacology·Yuan GaoTian Xie
Apr 26, 2021·Drug Discovery Today·Ganji Purnachandra NagarajuSarfraz Ahmad
Mar 28, 2021·Oral Diseases·Xi YangXueyi Liang
May 7, 2021·European Journal of Medicinal Chemistry·Ying-Chao DuanYuan-Yuan Guan
Jul 27, 2021·Rheumatology International·Reema R Barik, Lokesh Kumar Bhatt
Aug 28, 2021·Cancers·Haydee M TorresJianning Tao